Developing Biotherapeutics for Neurological Disorders

10 December 2018 09:30-17:20, London, United Kingdom

Introduction

Brain disorders such as: Alzheimer's disease, Parkinson's disease, epilepsy, cerebral vascular disease, including stroke, multiple sclerosis, brain trauma and migaine and their sequelae affect ~1bnpeople worldwide. The economic burden on health providers and governments is tremendous and worryingly this situation will escalate as the exected human life span increases. Throughout the world their are many interdisciplinary teams developing new therapeutic agents. Key research initiatives include: genomics, proteomics, cell imaging technologies,stem cell bioengineering, medicinal chemistry, molecular diagnostics, nanobiotechnology for drug delivery and biotherapeutics. Many significant advances have been made but still there remains a huge unmet clinical need for disease-modifying agents that will amelioare these distressing disorders.This conference will provide an unique opportunity for specialists to interact and create new collaborations. An important component of the conference is that it will provide good networking opportunities for students, to meet and question the experts and offers the chance to present a poster.

Deadlines

Useful links

Downloads

2018 neuroscience programme

Speakers

Venue

The 91AV

Science Room and Fish Room, The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

Contact information

91AV

Share: